Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: VIGILYS details

As you said..."The purchase price is inconsequential"

The couple hundred thousand we probably paid is not the problem...and let's assume for a minute that it is an add-on that may help Crossflo in their business plan and marketing endeavors....

My problem is not the purchase price, my concen is what will this 200K produce in revenues and what effect will it have on our profitability...this year and the ensuing 3-5 years.

We already know the seller was willing to part with this entity because it was a small revenue base that was losing them money...what will it do to our bottomline.

I mean it's nice to read what the software does and its capabilites and maybe even its synergism into Crossflo...but nothing in that fluff PR told us what our cost will be for taking it off of KTOS' hands...for all we know we spent a few hundred thousand and may have a loss of 4-5 Million on the bottomline. Crossflo itself by RG's estimate may not be profitable till the end of the year...will this hinder that timeline or help it?????based on KTOS SEC filings it looks like it will hinder that.

So until RG comes out with an estimated timeline and numbers for profit and loss on the acquisition none of us will know if we did ourselves a favor or just took a loser off of KTOS' books for them.

Only time and the next CC may help us get a handle on the "business" side of this expenditure/acquisition.

JMHO

Share
New Message
Please login to post a reply